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&iography in.53 pati&. There were no di&rencrs in 
lachycardia onset or recurrence had on accessmy connec- 
Lion locslion. Congenital heart defects were present am 37% 
of all patients, 23% al whom had EL&n’s anomaly. 
Supraventricular tochycardia associated with an accessory 
connection is the most common tachyanhythmia in children 
(I). Many reports (2-4) have suggested that Wollf- 
Parkinson-White syndrome and supraventricular tachycar- 
dia often disappear during the 1st year of life. However. it 
has also bee” suggested that tachycardia may rewr law 
(3.5). Therefore. the prognosis fur an infant with WoltT- 
Parkinson-White syndrome and supraventric”lar tachycar- 
dia is not clear. 
The purpose of this study was to determine whether 
specific clinical characteristics of Wolff-Parkinson-White 
s) ndrome or tachycardia could assist in medical and surgical 
decision-making in children. 
Methods 
Study patients. All patients from the Section of Pediatric 
Cardiology at Texas Children‘s Hospttal during the 20 years 
from I%8 to 1988 who had n surface electrocardiographic 
(ECGI dmgnosis of Wolff-Parkinson-White conduction and 
had lhelr firit episode of supraventriculartachycardia before 
IX years of age were included in this study. The diagnosis of 
prc-cwtation was made if the patier” had a shon PR mterval 
for age (6) and 8 delta wave. A full I? lcad ECG was required 
for every paucnt. Supraventricular mchycardia was defined 
LIP a narrow complex tachycardia, generally 220 to 300 
bcatsimin with surface features compatible with orthodromic 
reciprocating tachycardia. “Local” patietsts were defined as 
those from the surrounding NO telephone area codes 
ISoutheast Texas). “Referral” panents were from outside 
the local area. All patients were required to have KG 
ducumcmalmn of tachycardia (either in-hospital or on 
transtelephunic recordings) and records of prior therapy. 
Salients were excluded from rhe study if they were see” on 
only one occasion or had a followup study <I year after the 
imtml visit. Fwy paienx were thus excluded, 22 of whom 
were <? months of age. A total of 140 patient records were 
used for dnalys,s. 
Data analysis. The following data were recorded for each 
patient: cardiac anatomy (by echncsrdiography or cardiac 
catheterization). age at onset of supraventricular tachycar- 
dia, age at cessation or recurrence of tachycardia, or both, 
medications and uration of use, delta wave polarity in every 
surface ECG lead and location of the accessory connection 
by ei:hcr intracardiac electrophysiologic study ar estimation 
by surface ECG using the method of Gallagher et al. (7). 
Recurrence of supraventricular tachycardia was defined as 
an episode of rachycardia occurring >6 months after the 
patient’s initial episode. 
Statistics. Statistical analysis consisted of a I test for 
descriptive statistics and chi-square analysis for categorical 
data. Statistical significance was define,! as p < 0.05. 
Results 
Demographics. Of the 140 padtints in the study, 62% 
were male (p < 0.05). Seventy-six patients were considered 
local and 64 were referral patients as defined previously. The 
majority of referral patients were older children and adoles- 
cents referred for surgical intervention of their arrhythmia. 
Congenital heart defects (Table 1). Of the 140 patients. 52 
(32%) had a structural cardiac defect. The most common 
defect was Ebstein’s anomaly of the tricuspid valve. occur- 
ring in 12 (23%) of the 52 patients with a congenital heart 
defect. 
Pattern of taebyeardia epiwdes (Fig. 1). To examine the 
ages at which supraventricular tachycsrdia episodes began. 
data for initial tachycardia episodes and recurrent episodes 
are shown separately and pooled in Figure I. (The total 
number of episodes therefore xceeds the tolal number of 
patients.) The peak incidence of rupr~~entricutar tachycar- 
dm onset occurred from binh to 2 months of age (38% of the 
tofall. with a second peak of occurrence 133%) at 5 IO IO 
years of age. Of the 60 patients whose tachycardia first 
presented at 0 to 2 months of age, it disappeared by 8 months 
ofagein93%and persisted in7%. In6(3l%)ofthe 19infants 
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F@rr 1. Patient age at the time of initial (A) and recurrent (8) 
supmventricular tachycardia. A bimodal ewe is evident in the 
pookddatalCI. with peaks ~nthe newborn periodand ar6to8years 
ar age. ms. = patients. 
0 to 2 months of age. tachycardia disappeared and reap- 
peared cd an average age of 8 years. If tachycardia was 
present at >5 years of age. it was persistent in 78% of 
patients Who had not had surgical treatment) at a mean 
follow-up interval of 7 years. These patterns of txllycardia 
onset and disappearance were similar Soor local ad rzfcrral 
patients. 
Pa*ien*s willi 0 cowpenirul hrort deJ&r uere as hkely lo 
have rcwrrent supraventricular Uchycardia as acre pausnt\ 
without a congenital defect (31% ~erws 33%. rc~pcctwelyl 
(p = NS). This observation was unchanged when pstients 
with Ebstein’s malformation were considered separarcly 
from patients with other congcnita! defect. 
The surface ECG oppenronce ofpre-excirdm ws lwr irr 
34 (26%~ of the 140pntients. There was no relation belween 
the recurrence of tachycardia and the presence or disappear- 
ance of pre-excitation. 
Accessory conofflion hwatian (Fig. 2 to 4). The location of 
the accessory connection was mapped by electraphysiologic 
study in 87 patients and estimated by surface KG criteria in 
53 (Fig. 2). Tbe distribution of accessory connection loca- 
tions for all patients is shown in Figure 3. With UEC of the 
method of Gallagher et al. (7). the surface ECG correctly 
predicted elcctrophysiologic localization in 76% of patients 
who underwent cardiac cathetcrizatmn. The location of 
accessory connection did not influence the accuracy of 
surface ECG predictions. 
Of all 87 patients who underwent elestrophyriologic 
Figure 3. Distribution of acce~socy conncet~on locations in 110 
patients. Number, indicate numbers of pa~iems. 
study. 63% oi patients wth a conSeni&d heart defect had a 
right-sldcd xccssory connection, whereas 61% of patients 
wthout a congenital defect had a left-sided pathway (p i 
O.OtL All patients with Ebstein‘$ anomaly and atriovenfx- 
ulnr (AV) and ventriculoxtcrial concordance had a right- 
sided acccswry connection. If these patients zre excluded 
from analysk t Fig. 4). patients with a congenital heart defect 
had an equal distribution of right- and left-rid&i pathways 
(53% and 47%, respectively. p = NS). Multiple pathways 
were found at cathctcr!zalion in 3 (I?%) of 26 patients with 
a congenital bean defect and 4 (6%) of 61 patients with a 
normal heart. hut this dikrencc was not statistically signif- 
ant. , he three patients who had ventricular inversion 
(I-tranrpocnion) with “Ebstein’s” malformation of the left 
AV iaivc all had a left-sided pathway. 
Thclc were no dlffercnces in age of onset or age of 
rccurrcnce of supravcntricular tachvcardia based on the 
location of the accessory connection This ws true whether 
the lx&m w,bs proved in the csthe:rrizatioc laborakw or 
MS a.,umed by surface ECG fexdres. Patientr whose 
tachyc-rdm was persistent. beginwg initially either in in- 
fmcy :w in early childhood. had a broad spectrum of 
accessory connection locatllorks as well. 
Tacl;yawhythmia inducibility. Arnal fibrillation or atrial 
Rui!er was mduciblc in 10 (?I%) of the 87 patients at 
electrophysiologic study. There was no relation between the not arrhythmia. The second pstient had recurrent episodes 
location. of the accessory connection or presence of a con- of supraventric”lar tachycardia, type B pre-excitation and 
genital heart defect and the inducibility ofatrial fibrillation or ventricular fibrillation while taking digoxin. She had severe 
flutter. The mea” age of patients with inducible atrial tachy- cardiomegaly and died at 6 months of age with bradycardia 
arrhythmias was 12.2 2 5.5 versus 9.4 2 6.9 years for those and asystole soon after digoxi” therapy was reinstated for 
without inducible atrial tachyarrhythmias (p = 0.10). marked congestive heart failure. Endocardial libroelastosis 
It was not the purpose of this study to determine the was found at autopsy. 
influence of the accessory connection antemerade eLctive 
refractory period and shortest pre-excited RRinterval during 
atrial fibrillation or recurrent sumaventricular tachvcardia or Discussion 
sudden death. The indication fdr clectrophysiologi~ study in 
the vest majority of patients was recurrent tachycardia in 
anticipation of surgical intervention. Measurement of the 
electrophysiologic variables of the accessory connection 
war not routinely performed in asymptomatic infants and 
children u&o did not have tw,“rre”t tachycardia. The two 
deaths occurred early during the study period in patients 
who had not undergone electrophysiologic study. 
Drug therapy. Antiarrhythmic therapy bi the time of 
supraventricular tachycardia recurrence was recorded to 
assess whether the pattern of tachycardia episodes was 
modified by drugs. Many physicians were involved in the 
are of these patients. so choice of therapy was not uniform. 
Eliicacy was gers,,,y guided by Holter ECG monitoring or 
symptomatic episodes. 
Of rhe 37 porients who experienced recnrren~ mhycar- 
dia. 23 (62%) had been taking no antiarrhythmic medication 
for a period ranging from 6 months to 7 years. The remaining 
I4 pa!ie!:ts (38%) were receiving treatment at the time of 
tachycardia with one or “tore drugs including digoxin, 
propranolol. digoxi” plus propranolol, digoxin plus quini- 
dine. encainide or flecainide. The number of patients in each 
group was too small to allow statistical analysis of the 
influence of individual drug therapy a” recurrence. The 
WoUTParkinson-White syndrome and supraventricular 
tschycsrdia. This study shows that the vast majority (93%) 
of infants who experience supraventricular tachycardia as 
newborns will stop having episodes of tachycardia by 8 
months of age, but “early one third of them will have 
recurrent tachycardia at a mea” age of 8 years. Previous 
reports (3.8.9) have concluded that for infants with Wolfi- 
Parkinson-White syndrome and tachycardia, rec”rrent 
whycardia is rare later in life. Anatomically, the cessation 
of tachycardia and occasional loss of pre-excitation were 
believed by snne (IO) to be related to complete resorption of 
aberrant AV septal connections. Others (5.9) have shown a 
risk of tachycardia recurrence in these patients, but the 
timing of recurrence was not defined and the likelihood of 
recurrence W”E thought to be related to the presence of a 
coogenital heart defect or the location of the accessory 
connection. or both. A recent report by Klein et al. (II) 
concluded that many adult patients with Wolff-Parkinson- 
White syndrome lose anterograde conduction over the “c- 
cessory connection. These patients tended to be older (mea” 
age 50 years) and had longer anterograde accessory connec- 
tion refractory periods than did those in whom pre-excitation 
was persistent. Although there were no infants or children in 
their study, their data support the notion that “ccessorv 
mean age at recwrence was 7. I + 2.5 years for the group not connections may gradually&e the ability to conduct in later 
resewing drugs and 1.5 L+. 4.6 years fo: the group taking adult life. 
antianhythmic drugs (p = NS). Of the 56 patients‘withoui Recurrence of supraventricular taehycudia. The present 
recurrent tachycardia, 36 (64%) were taking antiarrhythmic 
drugs and 20 (34%) were not. There were 5 patients <I year 
study shows that a significant number of infants will experi- 
ence recwrent supraventricular tachvcardia in later child- 
of age with persistent tachycardia and 42 patients who were 
see” after I year of age and who did not have disappearance 
hood and that recu~rencc is not iaAue”~ed by the presence of 
of tachycardia. Antiarrhythmic drjgs therefore had a” influ- 
a congenital heart defect or the location of the accessop 
connection. The higher recurrence rate in this series may be 
ence on the likelihood of tachycardiP (p < 0.05). but not on secondary to imoroved detection (Holler monitori”& trans- 
the age at recurrence. 
All patients with a normal heart had palpitation or hemo- 
telephonic ECG &wdi”g) and exclusion of patients without 
dynamically well tolerated r”“s of supraventricub” tachy- 
documented follow-up. The finding that the age “1 recur- 
cardia at !he t!me of recurrence. wh:reaq. ?:~o of eight 
rence of tachycxdia is “at influenced by antiarrhythmic 
patients with a congenital heart defect experienced hcmody- 
therapy may imply that there are long periods when antiar- 
namic compromise. 
rhythmic therapy may be ““necessary for many asympto- 
matic young children. 
Sudden death. Two patients included in .his series died, A&l fibrillation and flutter. 
One patient with slnple ventricle. pulmonary stenosis and 
A major concern in patients 
with W&T-Parkinson-White svndrome is the raoid ventricu- 
“type B” pre-excitation died at 4 montln of age after lar response that may occur with atrial flutier or &~I 
surgery. This pat&l had persistent episode: of tachycardia fibrillation. Our dala showed that atrial fibrillation of flutter 
while receiving digoxi”, but the primary cause of death was was inducible at a mea” age of 12.2 years in patients With 
pze-excitation who underwent cardmc catheterization. This 
age was slightly older :han that of patients without Inducible 
atrial fibrillation or flutter. although the difference was “or 
statisticallv sitatificant. No w IS data exist a” the induc- 
ibility ofaitiaitihrillatio” o; flu&r I” ped~atrtc patients wth 
a normal heart. 
Surgical implications. More than 75% of patienfs viho had 
supraventricular tachycardia after age 5 years continued to 
have tachycardia throughout a mea” follow-up period or 7 
yeam. This observation may assist decision-maklog in pa. 
tients and in weighing the potential (irks and benefits of 
surgery. Surgical interven:ion should be considered I” the 
child in whom drug therapy is unsuccessful. when txhycar- 
dia affects the patient’s life-style, when cardiomy”pathy 6 
present, when iyncope “cc.urs& if the aoterognde &f&c 
refractory period of the accessory connection is short 
(1:,13). As children approach early adulthood. obtaining life 
insurance also becomes “o issue. Many insurance companies 
either will not insure or insure only at high premiums those 
patients with Wolff-Parkinson-White syndrome. If d patient 
is considered to have been surgically “cured” Ino delta 
wave and no tachycardia) for 2 years. standard rates arc 
generally available. 
Wolll-Parkinsao-White syndrome and con~eenitat heart dis 
ease. The association of the type B ECGpattem of pre- 
excitation in patients with “congenital heart defect has bee” 
reported previously (9). The present study points out mat 
when patients with Eb:.:in’s anomaly ore excluded, patients 
with a conaenital heart defect have oo equal distribution of 
right- and ieft-sided accessory connections. Additionally. 
the likelihood of recurrence of supraventricolar tachycardia 
was not influenced by the persistence of pre-excitation in 
sinus rhythm, the presence ofa congenital her< defect or the 
location of the pathway in patients in whom cathe!sr or 
operative mapping, or both. was petformed. 
Other factors alfeeling tschycardla recurrence. The 
finding that if tachycardia recurs it does so at a similar age 
rewdless Of theraDY lends credence to the notion that other 
factors affect the. Gmiog of arrhythmic episodes during 
childhood. The concept that aufonoro~ or bormondl cardio- 
vascular maturation occurs at this time (at about 8 years) is 
supported by the observations that this is the approximate 
age at which the symptom complex dssaciated with mitral 
valve prolapse occurs (14). vasodepressor syncope becomea 
evident and T waves in the tight chest leads begin to change 
w. 
Limilallons. Several limitations of the present study must 
be acknowledged. First, bwause it was a rerrospective 
study, there were no standardized means of followup eval- 
uation or treatment for many patients. Forty patients were 
excluded because of limbed follow-up data. Assuming they 
are well and not experiencing recurrent rachycardia. classi- 
fying these patients as having no recurrew would decrease 
the recwence rate from 31% to 23% for infants <Z months 
of age. 
Second. rhorr asymptomatic runs of tachycardm might 
not be rrported I” yo,mg children. In “or expeneoce, chil- 
dren >3 to 4 years of age gcocrally are capable of reponing 
palpimuon and sustained tachycardia. A prospective study 
of paticnls wth Wolff-Park&o”-White syndrome w&d 
employ more uniform out of hospita: monitoring to detect 
unwpected arrhythmia and add to ox knowleoge of age of 
recurrence and recurrence rates. 
Third. this is ““I a true “aturz2 history study becaube et 
the time of recurrent tachycardm. 38% of patients were 
taking antiarrhythmic medicodons and tbece drop could 
onI% the natural course oftachycardia. It is interesting to 
note. however. tha the ma” age of recurrence was simt:ar 
for patients whether they were or were not receiving antiar- 
rhythmic drugiherapy. 
Cooelosions. Supraveorr~~lar tachycardia due 1” Wolff- 
Wrhinwr.-What syndrome rhm begins in infancy may dis- 
appear. but II frequently recurs in later childhood at approx- 
imately X wars uf age. This potential gap in the prevalence of 
tachycxdia could allow long intervals when drugs are not 
necessary in early childhood for many patients. 
If supraventri~ular tachycardia is present after 5 years of 
age. it persists I” >lj% of patients. This knowledge should 
assist the physician, patient and parents in weighing the 
benefit< of surgical verses continued medical thempy. Addi- 
tionally. the study shows that knowledge of the location of 
the accessorv connection sod presence of a congenital heart 
defect does not help predict tie clinical coorsc of tachycar- 
did in chddren with Wolff-Parkinson-White svndmme. Pa 
tients with il congenital hean defect may be owrc likely ta 
have multiple pathways. possibly making surgical interven- 
tion more ditlicslt. 
Finally. ibis study shows a clustering of tachycardia 
episodes in the 5 to IO year age range. It is speculated that 
this clu>teri”g reflects autonomic or hormonal changes in the 
mechanisms of cardiovascular control occurring in early 
chi!dho”d. Funber investigation of this phenomenon will 
improve our undxstanding and management of patienrs with 
rachyarrhythmia:,. 

